Overview
The Khavinson bioregulator program represents one of the most extensive longitudinal peptide research efforts in modern gerontology. Developed over five decades by Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology, the program identified a family of short peptide bioregulators — typically 2-4 amino acids — derived from specific organ and tissue extracts that appear to restore gene expression patterns associated with youthful cellular function. Khavinson’s bioregulators have been studied in over 50,000 patients and subjects in Russian clinical and research settings, with findings published in peer-reviewed literature spanning immune function, organ-specific regeneration, and longevity outcomes. This article provides a research overview of the key compounds in the Khavinson protocol.
The Bioregulator Theory
Khavinson’s core hypothesis is that short peptides derived from specific tissues act as epigenetic regulators — interacting with DNA-histone complexes to modulate gene expression in a tissue-specific manner. As organisms age, these regulatory peptide signals decline, contributing to the deterioration of organ function. Supplementation with the appropriate bioregulators is hypothesized to partially restore youthful gene expression patterns. Structural biology research has shown that several Khavinson peptides bind to DNA promoter regions and histone proteins in ways consistent with this epigenetic regulatory model.
Key Compounds in the Protocol
Epithalon (Ala-Glu-Asp-Gly): The most extensively studied Khavinson bioregulator. Derived from the pineal gland extract Epithalamin. Studied for telomerase activation, telomere elongation, melatonin regulation, and longevity. Long-term studies report reduced cancer incidence and mortality in treated subjects. Thymalin: Derived from thymus extract. Studied for immune system restoration, particularly T-cell function in immunosenescence. Research documents improved immune parameters and reduced infection susceptibility in elderly populations. Vilon (Lys-Glu): The simplest Khavinson bioregulator — a dipeptide. Studied for thymic and immune regulation, T-lymphocyte activity, and longevity effects in animal models. Livagen: Derived from liver extract. Studied for hepatoprotection, immune modulation, and chromatin remodeling in lymphocytes. Pinealon (Glu-Asp-Arg): Derived from brain/pineal extract. Studied for cognitive function, neuroprotection, and circadian rhythm regulation. Research suggests improved cognitive performance and memory in age-related decline models. Vesugen (Lys-Glu-Asp): Derived from vessel/vascular extract. Studied for vascular protection, endothelial function, and cardiovascular aging research.
Longevity Research Findings
The most compelling data from the Khavinson program comes from long-term mortality studies. In a 15-year follow-up of elderly subjects receiving periodic Epithalon and Thymalin courses, treated groups showed 28-50% reduction in mortality compared to controls, along with lower cancer incidence. While much of this research originates from Russian institutions and requires independent replication in Western research frameworks, the longevity signal is consistent across multiple studies and has attracted growing international research interest. The biological plausibility of the telomere and epigenetic mechanisms is well-supported by independent molecular biology research.
Research Use Only
Khavinson bioregulators including Epithalon, Vilon, Pinealon, Livagen, and Vesugen are available from FenaLife for laboratory research use only. Not for human or veterinary use. Certificate of Analysis available per batch.
🔬 Research Compounds Referenced: BAC Water 10ml